Exacerbantes Study

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions
COPD Exacerbation
Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Sociedad Española de Neumología y Cirugía Torácica

OTHER